Current Report Filing (8-k)
2019年5月10日 - 8:44PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 10, 2019
POLARITYTE,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
000-51128
|
|
06-1529524
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
123
Wright Brothers Drive
Salt
Lake City, UT 84116
(Address
of principal executive offices and zip code)
Registrant’s
telephone number, including area code:
(800) 560-3983
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol
|
|
Name
of each exchange on which registered
|
Common
Stock, Par Value $0.001
|
|
PTE
|
|
Nasdaq
Capital Market
|
Item
7.01 Regulation FD Disclosure
On
May 10, 2019, PolarityTE, Inc., issued a press release entitled “PolarityTE Reports First Calendar Quarter 2019 Results,”
and a press release entitled “PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat
Lower Extremity Chronic Wounds Using SkinTE.”
Item
9.01. Financial Statements and Exhibits
(d)
Exhibits
.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
POLARITYTE,
INC.
|
|
|
Dated:
May 10, 2019
|
/s/
Paul Mann
|
|
Paul
Mann
|
|
Chief
Financial Officer
|
PolarityTE (NASDAQ:PTE)
過去 株価チャート
から 8 2024 まで 9 2024
PolarityTE (NASDAQ:PTE)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about PolarityTE Inc (ナスダック市場): 0 recent articles
その他のPolarityte, Inc.ニュース記事